PEG2000-DPSE-coated quercetin nanoparticles remarkably enhanced anticancer effects through induced programed cell death on C6 glioma cells

Journal of Biomedical Materials Research - Part A

Volumn 101, Issue 11, 2013, Pages 3076-3085

  Wang, Gang ^a   Wang, Junjie ^a   Luo, Jie ^a   Wang, Lei ^a   Chen, Xuanli ^a   Zhang, Liping ^a   Jiang, Shanqing ^a  

^a HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

apoptosis; mitochondrial pathway; nanoparticles; necrosis; PEG2000 DPSE; quercetin

Indexed keywords

DRUG DELIVERY VEHICLES; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PATHWAYS; NECROSIS; PEG2000-DPSE; PEGYLATED NANOPARTICLE; QUERCETIN; TUMOR CELL KILLINGS;

CELL DEATH; DRUG DELIVERY; FLAVONOIDS; MITOCHONDRIA; NANOPARTICLES; PROTEINS; TUMORS;

PHENOLS;

ACTIN; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 9; CYTOCHROME C; LACTATE DEHYDROGENASE; MACROGOL 2000; NANOCARRIER; PROTEIN P53; QUERCETIN;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DEATH; CELL KILLING; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG POTENTIATION; FLUORESCENCE MICROSCOPY; GLIOMA CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PARTICLE SIZE; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; ZETA POTENTIAL;

APOPTOSIS; MITOCHONDRIAL PATHWAY; NANOPARTICLES; NECROSIS; PEG2000-DPSE; QUERCETIN;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DEATH; CELL LINE, TUMOR; COATED MATERIALS, BIOCOMPATIBLE; GLIOMA; L-LACTATE DEHYDROGENASE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NANOPARTICLES; NECROSIS; POLYETHYLENE GLYCOLS; QUERCETIN; RATS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84884909668     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34607     Document Type: Article

References (38)

1. Bottini M, Bruckner S, Nika K, Bottini N, Bellucci S, Magrini A, Bergamaschi A, Mustelin T,. Multi-walled carbon nanotubes induce T lymphocyte apoptosis. Toxicol Lett 2006; 160: 121-126.
2. Cui D, Tian F, Ozkan CS, Wang M, Gao H,. Effect of single wall carbon nanotubes on human HEK293 cells. Toxicol Lett 2005; 155: 73-85.
3. Kuo JH, Jan MS, Chiu HW,. Mechanism of cell death induced by cationic dendrimers in RAW264.7 murine macrophage like cells. J Pharm Pharmacol 2005; 57: 489-495.
4. Lovric J, Cho SJ, Winnik FM, Maysinger D,. Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death. Chem Biol 2005; 12: 1227-1234.
5. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ,. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 2005; 19: 975-983.
6. Foley S, Crowley C, Smaihi M, Bonfils C, Erlanger BF, Seta P, Larroque C,. Cellular localisation of a water-soluble fullerene derivative. Biochem Biophys Res Commun 2002; 294: 116-119.
7. Isakovic A, Markovic Z, Todorovic-Markovic B, Nikolic N, Vranjes-Djuric S, Mirkovic M, Dramicanin M, Harhaji L, Raicevic N, Nikolic Z, Trajkovic V,. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene. Toxicol Sci 2006; 91: 173-183.
8. Qi LF, Xu ZR, Li Y, Jiang X, Han XY,. In vitro effect of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cells. World J Gastroenterol 2005; 11: 5136-5141.
9. Castro MG, Cowen R, Williamson IK, David A, Jimenez-Dalmaroni MJ, Yuan X, Bigliari A, Williams JC, Hu J, Lowenstein PR,. Current and future strategies for the treatment of malignant brain tumors. Pharmacol Ther 2003; 98: 71-108.
10. Zong WX, Thompson CB,. Necrotic death as a cell fate. Genes Dev 2006; 20: 1-15.
11. Heijnen CGM, Haenen GRMM, Van Acker FAA, Van Der Vijgh WJF, Bast A,. Flavonoids as peroxynitrite scavengers: The role of the hydroxyl groups. Toxicol In Vitro 2001; 15: 3-6.
12. Robaszkiewicz A, Balcerczyk A, Bartosz G,. Antioxidative and prooxidative effects of quercetin on A549 cells. Cell Biol Int 2007; 31: 1245-1250.
13. Lugli E, Ferraresi R, Roat E, Troiano L, Pinti M, Nasi M,. Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells. Leuk Res 2009; 33: 140-150.
14. Sagalowicz L, Leser ME,. Delivery systems for liquid food products. Curr Opin Colloid Interface Sci 2010; 15: 61-72.
15. Liu TZ, Chen CY, Yiin SJ, Chen CH, Cheng JT, Shih MK, Wang YS, Chern CL,. Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1). Food Chem Toxicol 2006; 44: 227-235.
16. Scherz-Shouval R, Elazar Z,. ROS, mitochondria and the regulation of autophagy. Trends Cell Biol 2007; 17: 422-427.
17. Macip S, Igarashi M, Berggren P, Yu J, Lee SW, Aaronson SA,. Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol Cell Biol 2003; 23: 8576-8585
18. Park CM, Park MJ, Kwak HJ, Moon SI, Yoo DH, Lee HC, Park IC, Rhee CH, Hong SI,. Induction of p53- mediated apoptosis and recovery of chemosensitivity through p53 transduction in human glioblastoma cells by cisplatin. Int J Oncol 2006; 28: 119-125.
19. Kuwabara M, Asanuma T, Niwa K, Inanami O,. Regulation of cell survival and death signals induced by oxidative stress. J Clin Biochem Nutr 2008; 43: 51-57.
20. Wang AZ, Gu F, Zhang L, Chan JM, Radovic-Moreno A, Shaikh MR, Farokhzad OC,. Biofunctionalized targeted nanoparticles for therapeutic applications. Expert Opin Biol Ther 2008; 8: 1063-1070.
21. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC,. Nanoparticles in medicine. Therapeutic applications and developments. Clin Pharmacol Ther 2008; 83: 761-769.
22. Alaouie AM, Sofou S,. Liposomes with triggered content release for cancer therapy. J Biomed Nanotech 2008; 4: 234-234.
23. Allen TM, Cullis PR,. Drug delivery systems: Entering the mainstream. Science 2004; 303: 1818-1822.
24. Allen TM,. Liposomes. Opportunities in drug delivery. Drugs 1997; 54: 8-14.
25. Gregoriadis G,. Homing of liposomes to target-cells. Biochem Soc Trans 1975; 3: 613-618.
26. Torchilin VP,. Liposomes as delivery agents for medical imaging. Mol Med Today 1996; 2: 242-249.
27. Papahadjopoulos D, Allen TM, Gabizon A, Mayhew E, Matthay K, Huang SK, Lee KD, Woodle MC, Lasic DD, Redemann C,. Sterically stabilized liposomes improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA 1991; 88: 11460-11464.
28. Gabizon A, Martin F,. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours. Drugs 1997; 54: 15-21.
29. Haran G, Cohen R, Bar LK, Barenholz Y,. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases [erratum]. Biochim Biophys Acta 1994; 23: 197.
30. Haran G, Cohen R, Bar LK, Barenholz Y,. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim Biophys Acta 1993; 1151: 201-215.
31. Johnston MJ, Edwards K, Karlsson G, Cullis PR,. Influence of drug-to-lipid ratio on drug release properties and liposome integrity in liposomal doxorubicin formulations. J Liposome Res 2008; 18: 145-157.
32. Ishizawa K, Yoshizumi M, Kawai Y, Terao J, Kihira Y, Ikeda Y, Tomita S, Minakuchi K, Tsuchiya K, Tamaki T,. Pharmacology in health food: Metabolism of quercetin in vivo and its protective effect against arteriosclerosis. J Pharmacol Sci 2011; 115: 466-470.
33. Zhang M, Swarts SG, Yin L, Liu C, Tian Y, Cao Y, Swarts M, Yang S, Zhang SB, Zhang K, Ju S, Olek DJ Jr, Schwartz L, Keng PC, Howell R, Zhang L, Okunieff P,. Antioxidant properties of quercetin. Adv Exp Med Biol 2011; 701: 283-289.
34. Park MH, Min do S,. Quercetin-induced downregulation of phospholipase D1 inhibits proliferation and invasion in U87 glioma cells. Biochem Biophys Res Commun 2011; 412: 710-715.
35. Boots AW, Balk JM, Bast A, Haenen GR,. The reversibility of the glutathionyl-quercetin adduct spreads oxidized quercetin- induced toxicity. Biochem Biophys Res Commun 2005; 338: 923-929.
36. Boots AW, Li H, Schins RP, Duffin R, Heemskerk JW, Bast A, Haenen GR,. The quercetin paradox. Toxicol Appl Pharmacol 2007; 222: 89-96.
37. Ferraresi R, Troiano L, Roat E, Lugli E, Nemes E, Nasi M,. " Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin." Free Radic Res 2005; 39: 1249-1258.
38. de Vries HE, Witte M, Hondius D, Rozemuller AJ, Drukarch B, Hoozemans J, van Horssen J,. Nrf2-induced antioxidant protection: A promising target to counteract ROS- mediated damage in neurodegenerative disease? Free Radic Biol Med 2008; 45: 1375-1383.